Evaluating the effect of ultrasound guided pacemaker or defibrillator lead implantation on tricuspid regurgitation.

Not Applicable

• Conditions: Tricuspid Regurgitation; Cardiovascular - Other cardiovascular diseases; Surgery - Other surgery

• Registration Number: ACTRN12620001070921
• Lead Sponsor: Royal Prince Alfred Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-10-19
• Last Update Posted: 26 October 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 125

Inclusion Criteria

1.Clinical indication for device implantation (permanent pacemaker or debfibrillator)
2.Greater than or equal to 18 years of age
3.Able to provide informed consent

Exclusion Criteria

1.Previous endocardial lead
2.Moderate or greater tricuspid regurgitation on baseline transthoracic echocardiography
3.Moderate or severe right ventricular dilatation or systolic dysfunction
4.Estimated right ventricular systolic pressure >70mmHg
5.Suboptimal 3D-TOE images at time of device-implantation
6.Unable to attend 6-month follow up at a designated echo centre.
7. Complete heart block
8. Rapid atrial fibrillation
9. More than one lead across tricuspid valve planned (E.g. His bundle backup lead)

Study & Design

• Study Type: Interventional
• Study Design: Not specified